Följ
Pille Taba
Pille Taba
Professor of Neurology
Verifierad e-postadress på kliinikum.ee
Titel
Citeras av
Citeras av
År
Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies
MA Nalls, C Blauwendraat, CL Vallerga, K Heilbron, S Bandres-Ciga, ...
The Lancet Neurology 18 (12), 1091-1102, 2019
14372019
EFNS/MDS‐ES recommendations for the diagnosis of P arkinson's disease
A Berardelli, GK Wenning, A Antonini, D Berg, BR Bloem, V Bonifati, ...
European Journal of Neurology 20 (1), 16-34, 2013
6102013
EAN consensus review on prevention, diagnosis and management of tick‐borne encephalitis
P Taba, E Schmutzhard, P Forsberg, I Lutsar, U Ljøstad, Å Mygland, ...
European journal of neurology 24 (10), 1214-e61, 2017
2152017
Parkinson’s disease in GTP cyclohydrolase 1 mutation carriers
NE Mencacci, IU Isaias, MM Reich, C Ganos, V Plagnol, JM Polke, J Bras, ...
Brain 137 (9), 2480-2492, 2014
2092014
Health-related quality of life in Parkinson’s disease: a cross-sectional study focusing on non-motor symptoms
L Kadastik-Eerme, M Rosenthal, T Paju, M Muldmaa, P Taba
Health and quality of life outcomes 13, 1-8, 2015
1502015
The international European Academy of Neurology survey on neurological symptoms in patients with COVID‐19 infection
E Moro, A Priori, E Beghi, R Helbok, L Campiglio, CL Bassetti, E Bianchi, ...
European journal of neurology 27 (9), 1727-1737, 2020
1262020
Barriers and facilitators to the implementation of clinical practice guidelines: a cross-sectional survey among physicians in Estonia
P Taba, M Rosenthal, J Habicht, H Tarien, M Mathiesen, S Hill, L Bero
BMC health services research 12 (1), 1-7, 2012
1062012
Patient education in Parkinson's disease: formative evaluation of a standardized programme in seven European countries
M Macht, C Gerlich, H Ellgring, M Schradi, ÀB Rusiñol, M Crespo, A Prats, ...
Patient education and counseling 65 (2), 245-252, 2007
1062007
A systematic review of neurological manifestations of SARS‐CoV‐2 infection: the devil is hidden in the details
M Romoli, I Jelcic, R Bernard‐Valnet, D García Azorín, L Mancinelli, ...
European journal of neurology 27 (9), 1712-1726, 2020
1052020
Identification of candidate Parkinson disease genes by integrating genome-wide association study, expression, and epigenetic data sets
DA Kia, D Zhang, S Guelfi, C Manzoni, L Hubbard, RH Reynolds, J Botía, ...
JAMA neurology 78 (4), 464-472, 2021
1002021
Leg-extension strength and chair-rise performance in elderly women with Parkinson’s disease
M Pääsuke, J Ereline, H Gapeyeva, K Joost, K Mõttus, P Taba
Journal of Aging and Physical Activity 12 (4), 511-524, 2004
1002004
Differences in MDS‐UPDRS scores based on Hoehn and Yahr stage and disease duration
M Skorvanek, P Martinez‐Martin, N Kovacs, M Rodriguez‐Violante, ...
Movement disorders clinical practice 4 (4), 536-544, 2017
992017
Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset
KJ Billingsley, IA Barbosa, S Bandrés-Ciga, JP Quinn, VJ Bubb, ...
npj Parkinson's Disease 5 (1), 8, 2019
952019
Neurosyphilis
H Gonzalez, I Koralnik, D Edmondson, B Hu, S Norris, D Thomas, ...
Seminars in neurology 39 (04), 448-455, 2019
912019
Manganese-induced parkinsonism due to ephedrone abuse
K Sikk, S Haldre, SM Aquilonius, P Taba
Parkinson’s Disease 2011, 2011
912011
Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson’s disease
G Liu, J Peng, Z Liao, JJ Locascio, JC Corvol, F Zhu, X Dong, ...
Nature genetics 53 (6), 787-793, 2021
902021
Irreversible motor impairment in young addicts–ephedrone, manganism or both?
K Sikk, P Taba, S Haldre, J Bergquist, D Nyholm, G Zjablov, T Asser, ...
Acta Neurologica Scandinavica 115 (6), 385-389, 2007
892007
Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson’s disease heritability
RH Reynolds, J Botía, MA Nalls, J Hardy, SA Gagliano Taliun, M Ryten
npj Parkinson's Disease 5 (1), 6, 2019
872019
The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease
S Bandres‐Ciga, S Saez‐Atienzar, L Bonet‐Ponce, K Billingsley, D Vitale, ...
Movement Disorders 34 (4), 460-468, 2019
772019
Psychostimulants and movement disorders
A Asser, P Taba
Frontiers in neurology 6, 75, 2015
772015
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20